BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26027998)

  • 1. Tumefactive Demyelinating Lesion Differentiated from a Brain Tumor Using a Combination of Magnetic Resonance Imaging and (11)C-methionine Positron Emission Tomography.
    Ninomiya S; Hara M; Morita A; Teramoto H; Momose M; Takahashi T; Kamei S
    Intern Med; 2015; 54(11):1411-4. PubMed ID: 26027998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frontal Tumefactive Demyelinating Lesion Mimicking Glioblastoma Differentiated by Methionine Positron Emission Tomography.
    Yasuda S; Yano H; Kimura A; Suzui N; Nakayama N; Shinoda J; Iwama T
    World Neurosurg; 2018 Nov; 119():244-248. PubMed ID: 30114544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of [
    Hashimoto S; Inaji M; Nariai T; Kobayashi D; Sanjo N; Yokota T; Ishii K; Taketoshi M
    Neurol Med Chir (Tokyo); 2019 May; 59(5):176-183. PubMed ID: 30996153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour-like lesions in multiple sclerosis.
    Jamroz-Wiśniewska A; Janczarek M; Belniak E; Stelmasiak Z; Bartosik-Psujek H
    Neurol Neurochir Pol; 2008; 42(2):161-7. PubMed ID: 18512174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional imaging of a large demyelinating lesion.
    Padma MV; Adineh M; Pugar K; Mukherjee J; Satter M; Shi B; Dunigan K; Bidwell K; Ezzeddine B; Mantil J
    J Clin Neurosci; 2005 Feb; 12(2):176-8. PubMed ID: 15749424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of PET imaging in differential diagnostics between a tumefactive multiple sclerosis lesion and low-grade glioma.
    Tarkkonen A; Rissanen E; Tuokkola T; Airas L
    Mult Scler Relat Disord; 2016 Sep; 9():147-9. PubMed ID: 27645363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study.
    Altintas A; Petek B; Isik N; Terzi M; Bolukbasi F; Tavsanli M; Saip S; Boz C; Aydin T; Arici-Duz O; Ozer F; Siva A
    Mult Scler; 2012 Oct; 18(10):1448-53. PubMed ID: 22419670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumefactive demyelinating lesions: A comprehensive review.
    Algahtani H; Shirah B; Alassiri A
    Mult Scler Relat Disord; 2017 May; 14():72-79. PubMed ID: 28619436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis of pediatric multiple sclerosis initially presenting with tumefactive demyelinating lesion using ¹H-magnetic resonance spectroscopy].
    Kageyama T; Gotoh Y; Sano F; Katoh T; Nambu M; Okada T; Suenaga T
    Rinsho Shinkeigaku; 2011 Sep; 51(9):688-93. PubMed ID: 21946426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass lesions in the brain: tumor or multiple sclerosis? Clinical and imaging characteristics and course from a single reference center.
    Kilic AK; Kurne AT; Oguz KK; Soylemezoglu F; Karabudak R
    Turk Neurosurg; 2013; 23(6):728-35. PubMed ID: 24310455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic assessment of monofocal acute inflammatory demyelination using MR spectroscopy and (11)C-methionine-, (11)C-choline-, and (18)F-fluorodeoxyglucose-PET.
    Takenaka S; Shinoda J; Asano Y; Aki T; Miwa K; Ito T; Yokoyama K; Iwama T
    Brain Tumor Pathol; 2011 Jul; 28(3):229-38. PubMed ID: 21442242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and magnetic resonance imaging (MRI) distinctions between tumefactive demyelination and brain tumors in children.
    Yiu EM; Laughlin S; Verhey LH; Banwell BL;
    J Child Neurol; 2014 May; 29(5):654-65. PubMed ID: 24092896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiologic MRI of a tumefactive multiple sclerosis lesion.
    Ernst T; Chang L; Walot I; Huff K
    Neurology; 1998 Nov; 51(5):1486-8. PubMed ID: 9818892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of 18F-FDG and 11C-MET PET-CT in differentiation of brain ringlike-enhanced neoplastic and non-neoplastic lesions on MRI imaging].
    Cai L; Gao S; Li DC; Li YS; Chen QS; Xing XL
    Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):134-8. PubMed ID: 19538892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectroscopic magnetic resonance imaging of a tumefactive demyelinating lesion.
    Law M; Meltzer DE; Cha S
    Neuroradiology; 2002 Dec; 44(12):986-9. PubMed ID: 12483443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient Focal Magnetic Resonance Imaging Abnormalities After Status Epilepticus Showed 11C-Methionine Uptake with Positron Emission Tomography in a Patient with Cerebral Cavernous Malformation.
    Ishiguro T; Nitta M; Komori T; Maruyama T; Muragaki Y; Kawamata T
    World Neurosurg; 2018 Jun; 114():43-46. PubMed ID: 29530707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumefactive demyelinating lesion: experience with two unusual patients.
    Sinha MK; Garg RK; Bhatt ML; Chandra A
    J Postgrad Med; 2010; 56(2):146-9. PubMed ID: 20622396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical interest of integrating positron emission tomography imaging in the workup of 55 children with incidentally diagnosed brain lesions.
    Pirotte BJ; Lubansu A; Massager N; Wikler D; Van Bogaert P; Levivier M; Brotchi J; Goldman S
    J Neurosurg Pediatr; 2010 May; 5(5):479-85. PubMed ID: 20433262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy.
    Terakawa Y; Tsuyuguchi N; Iwai Y; Yamanaka K; Higashiyama S; Takami T; Ohata K
    J Nucl Med; 2008 May; 49(5):694-9. PubMed ID: 18413375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced accuracy in differential diagnosis of radiation necrosis by positron emission tomography-magnetic resonance imaging coregistration: technical case report.
    Thiel A; Pietrzyk U; Sturm V; Herholz K; Hövels M; Schröder R
    Neurosurgery; 2000 Jan; 46(1):232-4. PubMed ID: 10626957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.